Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1259940
Name of medicinal product: Virbagen Omega
Active substances:
Recombinant Omega interferone of feline origin
Estonian, English, Latin
ATC code: QL03AB90
Dosage form: lyophilisate and solvent for suspension for injection
Route of administration: subcutaneous use; intravenous use
Strengh: 5000000ühik
Amount in package: 5TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information: lahusti 1 ml
Indication: Dogs : Reduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. Cats : Treatment of cats infected with FeLV and/or FIV, in non-terminal clinical stages, from the age of 9 weeks. In a field study conducted, it was observed that there was : - a reduction of clinical signs during the symptomatic phase (4 months) - a reduction of mortality : • in anaemic cats, mortality rate of about 60% at 4, 6, 9 and 12 months was reduced by approximately 30% following treatment with interferon. • in non-anaemic cats, mortality rate of 50 % in cats infected by FeLV was reduced by 20% following treatment with interferon. In cats infected by FIV, mortality was low (5%) and was not influenced by the treatment.
Safety features: No
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Withdrawal time: Ei rakendata.
Species: koer, kass
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Virbac 
Marketing authorization number: EU/2/01/030 
Marketing authorization issued on: November 6, 2001 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Entry/Changing date: November 23, 2011
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere